Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

NCT01835223 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Advanced Adult Hepatocellular Carcinoma
Non-Resectable Hepatocellular Carcinoma

Interventions

DRUG: Tivozanib (1mg)
DRUG: Tivozanib (1.5mg)

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]